Filing Details

Accession Number:
0001654954-19-002991
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-20 16:21:29
Reporting Period:
2019-03-18
Accepted Time:
2019-03-20 16:21:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489798 Janet Dillione C/o Cormedix Inc.
400 Connell Drive, Suite 5000
Berkeley Heights NJ 07922
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-18 42,000 $1.67 180,909 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Phantom Stock $0.00 4,213 4,213 Direct
Common Stock Stock Option (Right to Buy Common Stock) $1.66 2029-01-10 75,000 75,000 Direct
Common Stock Phantom Stock $0.00 6,637 6,637 Direct
Common Stock Phantom Stock $0.00 13,636 13,636 Direct
Common Stock Phantom Stock $0.00 37,500 37,500 Direct
Common Stock Stock Option (Right to Buy Common Stock) $0.57 2028-02-16 40,000 40,000 Direct
Common Stock Phantom Stock $0.00 13,392 13,392 Direct
Common Stock Phantom Stock $0.00 15,625 15,625 Direct
Common Stock Phantom Stock $0.00 20,833 20,833 Direct
Common Stock Stock Option (Right to Buy Common Stock) $2.24 2027-02-21 40,000 40,000 Direct
Common Stock Phantom Stock $0.00 3,472 3,472 Direct
Common Stock Phantom Stock $0.00 4,143 4,143 Direct
Common Stock Stock Option (Right to Buy Common Stock) $3.03 2025-08-11 50,000 50,000 Direct
Common Stock Phantom Stock $0.00 1,415 1,415 Direct
Common Stock Stock Option (Right to Buy Common Stock) $3.03 2026-02-21 95,000 95,000 Direct
Common Stock Phantom Stock $0.00 3,831 3,831 Direct
Common Stock Phantom Stock $0.00 2,767 2,767 Direct
Common Stock Phantom Stock $0.00 4,335 4,335 Direct
Common Stock Phantom Stock $0.00 15,306 15,306 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
4,213 4,213 Direct
2029-01-10 75,000 75,000 Direct
6,637 6,637 Direct
13,636 13,636 Direct
37,500 37,500 Direct
2028-02-16 40,000 40,000 Direct
13,392 13,392 Direct
15,625 15,625 Direct
20,833 20,833 Direct
2027-02-21 40,000 40,000 Direct
3,472 3,472 Direct
4,143 4,143 Direct
2025-08-11 50,000 50,000 Direct
1,415 1,415 Direct
2026-02-21 95,000 95,000 Direct
3,831 3,831 Direct
2,767 2,767 Direct
4,335 4,335 Direct
15,306 15,306 Direct
Footnotes
  1. Represents the weighted average purchase price of the shares purchased from a low of $1.655 to a high of $1.670 per share.
  2. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  3. These options were granted on 01/10/2019. The options vest monthly with 100% vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  4. These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  5. These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  6. These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
  7. These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.